Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy iCAD stock
Own iCAD stock in just a few minutes.
iCAD, Inc is a health information services business based in the US. iCAD shares (ICAD) are listed on the NASDAQ and all prices are listed in US Dollars. iCAD employs 113 staff and has a trailing 12-month revenue of around USD$29.7 million.
How to buy shares in iCAD
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for iCAD. Find the stock by name or ticker symbol: ICAD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until iCAD reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of iCAD, depending on your broker.
- Check in on your investment. Congratulations, you own a part of iCAD. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
iCAD share price
Use our graph to track the performance of ICAD stocks over time.iCAD shares at a glance
Information last updated 2021-04-15.
| 52-week range | USD$8.32 - USD$21.44 |
|---|---|
| 50-day moving average | USD$18.8118 |
| 200-day moving average | USD$13.9559 |
| Wall St. target price | USD$23.22 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.703 |
Buy iCAD shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy iCAD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
iCAD financials
| Revenue TTM | USD$29.7 million |
|---|---|
| Gross profit TTM | USD$21.7 million |
| Return on assets TTM | -12.06% |
| Return on equity TTM | -98.94% |
| Profit margin | -59.3% |
| Book value | $1.298 |
| Market capitalisation | USD$468 million |
TTM: trailing 12 months
Shorting iCAD shares
There are currently 785,104 iCAD shares held short by investors – that's known as iCAD's "short interest". This figure is 0.9% up from 778,055 last month.
There are a few different ways that this level of interest in shorting iCAD shares can be evaluated.
iCAD's "short interest ratio" (SIR)
iCAD's "short interest ratio" (SIR) is the quantity of iCAD shares currently shorted divided by the average quantity of iCAD shares traded daily (recently around 257411.14754098). iCAD's SIR currently stands at 3.05. In other words for every 100,000 iCAD shares traded daily on the market, roughly 3050 shares are currently held short.
However iCAD's short interest can also be evaluated against the total number of iCAD shares, or, against the total number of tradable iCAD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iCAD's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 iCAD shares in existence, roughly 30 shares are currently held short) or 0.0343% of the tradable shares (for every 100,000 tradable iCAD shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iCAD.
Find out more about how you can short iCAD stock.
iCAD share dividends
We're not expecting iCAD to pay a dividend over the next 12 months.
Have iCAD's shares ever split?
iCAD's shares were split on a 1:5 basis on 15 August 2012. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your iCAD shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for iCAD shares which in turn could have impacted iCAD's share price.
iCAD share price volatility
Over the last 12 months, iCAD's shares have ranged in value from as little as $8.32 up to $21.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while iCAD's is 1.2504. This would suggest that iCAD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
iCAD overview
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company serves healthcare centers through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert